Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

All skin diseases might start in hair follicles.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Fzd2 is important for skin and hair development through various signaling ways.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Cell-based therapies offer better repigmentation for larger vitiligo areas, with CD8+ T cell count as a potential biomarker for success.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Trichoscopy can help diagnose early congenital syphilis in newborns.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

SQSTM1 gene issues may increase the risk of alopecia areata.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

GLP-1 agonists may help treat certain skin conditions.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.